Hyperprogression and Immune Checkpoint Inhibitors: Hype or Progress?

Oncologist - United States
doi 10.1634/theoncologist.2019-0636
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press


Related search